Smith And Nephew Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SMITH AND NEPHEW
SMITH AND NEPHEW has forty-two approved drugs.
Drugs and US Patents for Smith And Nephew
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 089251-001 | Dec 4, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 070023-001 | Feb 5, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | NITROGLYCERIN | nitroglycerin | INJECTABLE;INJECTION | 070634-001 | Jun 19, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

